Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MASCOT: FOLFOX4 in Asian Adjuvant Colon Cancer
NCT00263055Phase 4Completed
- Sponsor
- Sanofi
- Start
- Aug 2004
- Primary completion
- Jun 2005
- Modality
- DNA Intercalators/Alkylators
- Countries
- 5
01
Overview
Phase 4, open-label, single-arm trial of oxaliplatin in colon cancer, sponsored by Sanofi. Primary endpoint: Occurrence of dose-limiting toxicity. Started Aug 2004; status: completed.
02
Drugs
oxaliplatin
03
Conditions
colon cancer
Beyond the preview
Go deeper on NCT00263055.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00263055.